Galapagos NV
GLPG
#4563
Rank
ยฃ1.58 B
Marketcap
ยฃ23.71
Share price
-0.57%
Change (1 day)
12.27%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -ยฃ0.4 Billion

According to Galapagos NV's latest financial reports the company's current earnings are ยฃ0.32 Billion. In 2024 the company made an earning of -ยฃ4.34 Million, an increase over its 2023 earnings that were of -ยฃ25.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.4 Billion9078.85%
2024 -ยฃ4.34 Million-82.77%
2023 -ยฃ25.18 Million-85.59%
2022 -ยฃ0.18 Billion60.71%
2021 -ยฃ0.11 Billion-60.08%
2020 -ยฃ0.28 Billion-331.44%
2019 ยฃ0.11 B-523.76%
2018 -ยฃ27.78 Million-72.34%
2017 -ยฃ0.11 Billion-329.59%
2016 ยฃ43.74 M-144.3%
2015 -ยฃ98.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AstraZeneca
AZN
ยฃ9.82 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
ยฃ24.31 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.83 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
ยฃ1.24 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-ยฃ66.77 Million-83.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.10 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.33 B-432.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
ยฃ6.99 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
ยฃ17.33 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA